Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Vaccinations

Vaccinations

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...

Immunodeficiency Diseases

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...

Sexually Transmitted Infections

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Insights into Persistent SARS-CoV-2 Reservoirs in Chronic Long COVID.

Viruses·2025

Same author

A Multi-Antigen Broad-Spectrum Coronavirus Vaccine Induces Potent and Durable Cross-Protection Against Infection and Disease Caused by Multiple SARS-CoV-2 Variants.

Research square·2025

Same author

A pan-beta-coronavirus vaccine bearing conserved and asymptomatic B- and T-cell epitopes protects against highly pathogenic Delta and highly transmissible Omicron SARS-CoV-2 variants.

Human vaccines & immunotherapeutics·2025

Same author

Dynamics of spike-specific neutralizing antibodies across five-year emerging SARS-CoV-2 variants of concern reveal conserved epitopes that protect against severe COVID-19.

Frontiers in immunology·2025

Same author

Antigen Delivery Platforms for Next-Generation Coronavirus Vaccines.

Vaccines·2025

Same author

Dynamics of Spike-Specific Neutralizing Antibodies Across Five-Year Emerging SARS-CoV-2 Variants of Concern Reveal Conserved Epitopes that Protect Against Severe COVID-19.

bioRxiv : the preprint server for biology·2024

Search research articles

Related Experiment Video

Updated: Jun 23, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

DNA vaccines for HIV/AIDS.

Jeffrey B Ulmer¹, Britta Wahren, Margaret A Liu

¹Novartis Vaccines, Emeryville, California, USA.

Current Opinion in HIV and AIDS

|April 18, 2009

Summary

Advances in DNA vaccines, including improved potency and delivery, show promise for human immunodeficiency virus (HIV) vaccines. These gene-based vaccines are being developed for clinical use.

Area of Science:

Vaccinology
Molecular Biology
Immunology

Background:

DNA vaccines have overcome previous limitations in potency and delivery, as evidenced by veterinary applications.
The development of effective vaccines against Human Immunodeficiency Virus (HIV) remains a critical global health challenge.

Purpose of the Study:

To review recent advancements in DNA vaccine technology.
To evaluate the potential of these advancements for the development of an HIV vaccine for human use.

Main Methods:

Review of novel formulations and delivery methods for DNA vaccines.
Analysis of adjuvant and immune modulator strategies to enhance immune responses.
Evaluation of heterologous prime/boost strategies using DNA vaccines.
Consideration of results from early-phase clinical trials and nonhuman primate studies.

More Related Videos

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

Related Experiment Videos

Last Updated: Jun 23, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

Main Results:

New formulations and delivery methods have significantly increased DNA vaccine potency.
Adjuvants and immune modulators enhance and focus immune responses.
Heterologous prime/boost strategies improve both antibody and cellular responses.
Early clinical trial data are guiding gene-based vaccine development.

Conclusions:

Recent DNA vaccine advancements offer significant potential for developing a clinical HIV/AIDS vaccine.
Novel adjuvants, formulations, delivery systems, and prime/boost strategies are key areas of progress.
Continued research and clinical evaluation are essential for translating these advances into an effective HIV vaccine.